Why on earth should we continue to invest in the male condom?

Why on earth should we continue to invest in the male condom? J. Stovera, J Rosena, N Carvalhoa, HS Friedmanb, M Coganb, a Avenir Health, b UNFPA and ...
Author: Zoe Baker
0 downloads 0 Views 1MB Size
Why on earth should we continue to invest in the male condom? J. Stovera, J Rosena, N Carvalhoa, HS Friedmanb, M Coganb, a Avenir Health, b UNFPA and B Deperthesb 9th IAEN Pre-Conference, Durban, South Africa 16 July 2016 – Parallel Session F

Introduction 

Male condom* protects against pregnancy and transmission of sexually transmitted infections(STIs), including human immunodeficiency virus(HIV)



As support and investment in condom programming stagnating globally, it is critical to document whether condoms continue to be strategic and costeffective investments for family planning(FP) and the prevention of HIV and other STIs.

Scope  Analysis countries

o 75 Countdown to 2015 countries o 6 additional UNAIDS Fast-Track to 2030 countries

 Timeframe o 2015-2030  Scenarios

Baseline: Condom use levels from 2015 are held constant 2015

Medium: Historical trends in condom use from 2016-2030

High: Scaling up condom use to meet all unmet need for FP and scale up condom use for HIV and STI prevention to 90% by 2016

2030

Triple Protection





FP condom users: those using condoms as primary method of family planning; also protected against HIV/STIs Condom users for HIV/STI protection: those at medium and high risk of HIV and STI transmission; no pregnancy protection

Using condoms for protection from unintended pregnancy (low risk of HIV/STI)

Using condoms for STI protection (medium and high risk of HIV/STI transmission; low risk for family planning)

Using condoms for HIV protection (medium and high risk of HIV/STI transmission; low risk for family planning)

Methodology: Number of Condoms Used and Needed Family Planning • Condom use: # of women of reproductive age x mCPR among all women x proportion of condom method mix among all women x 120 CYP • Condom need: # of women of reproductive age x [mCPR among all women + unmet need] x condom share x 120 CYP

HIV and STI Prevention • Condom use among key population groups: female sex workers (FSW), men who have sex with men (MSM), transgenders, prisoners, people with multiple partners, and sero-discordant couples • Condom need: 90% of risky acts covered

Gap in Condoms = Condoms needed – current condom use

Methodology: Cost per Condom Distributed • Public sector: $0.05 - $0.08 Weissman, 2014: RH Costing Tool Commodities, labor, program support

• Social marketing: $0.18 ($0.04 - $ 3.42) PSI, Annual Cost Effectiveness Report Commodities, distribution, packaging, promotion

Methodology: Effectiveness of Condoms Component Impact

Effectiveness

Source

Family planning

Unintended pregnancies averted

90%

Cleland, Ali, Shah, UNPD, 2006

HIV

HIV infections averted

80%

Weller and Davis, Cochrane Review, 2002

STIs

Cases averted: Syphilis Gonorrhea Chlamydia HSV-2

29% 56% 38% 29%

Holmes et al. Bull WHO, 2004

Findings: Condom Gap Current Use and Need for Condoms, 2015, billions 30

Current Use

Need 26.7

25

20

15

15.8 13.8

12.9 10

8.3

7.5

5

0

Family Planning

HIV/STI Prevention

Total

Findings: Total Cost of Condoms (billions US$, 2015-2030)

Baseline

Medium

High

Family Planning

$25

$26

$30

HIV and STI Prevention

$35

$35

$57

$15

$15

$16

$6

$6

$8

Transgenders

$1

$1

$1

Multiple partners

$12

$13

$30

$1

$1

$2

$1

$1

$1

$60

$62

$87

Sex Workers Men who have sex w men

Sero-discordant couples Prisoners

GRAND TOTAL

Findings: Incremental Cost (millions US$, 2015-2030)

Medium vs Low Scenario

High vs Low Scenario

$1,180

$5,170

HIV and STI Prevention

$718

$22,500

Total

$1,900

$27,600

Family Planning

Findings: Impact 2015-2030

Area

Impact

Family planning

420M births averted

HIV

17M infections averted

200M

STIs

730M infections averted

30M

Total

DALYs Averted (High-Low) 5M

240M

Findings: Total Condom Effectiveness (2015-2030)

Incremental Cost ($ millions)

Incremental Effectiveness (DALYs averted), millions Incremental CostEffectiveness Ratio (ICER)

Medium over Low

High over Low

$1,900

$27,600

6.2

240

$304 ($33 - $540)

$115 ($43 - $212)

Cost-Effectiveness of HIV/STI/FP Interventions (Cost/DALY averted, US$ 2015)

Published studies on other family planning, HIV and STI interventions show costs per DALY averted ranging from $3 - $1100

Discussion  Condoms are highly cost-effective investments!  Meeting all demand for condom use would have a large health impact!

Q&A